Psoriatic onychodystrophy: indices for assessing the severity of psoriatic onychodystrophy (part 2)

Cover Page

Abstract


Psoriatic onychodystrophy constitutes an important clinical manifestation of psoriasis and is characterised by multiple symptoms of damage to the nail bed and nail matrix. In order to determine the severity of psoriatic onychodystrophy, as well as the therapeutic efficacy of medications, a unified scale is needed. The article describes the most common indices: NAPSI, mNAPSI, target NAPSI, NAS, PNSS, Baran scale, N-NAIL. In this work, the authors present a methodology for working with each of them, as well as a comparative analysis of detectable symptoms. The conducted literature review indicates the absence of a universal index for assessing the severity of psoriatic onychodystrophy and determines the need to search for new diagnostic algorithms.


About the authors

A. V. Platonova

S.M. Kirov Military Medical Academy, Ministry of Defence of the Russian Federation

Email: platonova1105@gmail.com

Russian Federation PhD researcher, Department of Skin and Venereal Diseases

A. S. Zhukov

S.M. Kirov Military Medical Academy, Ministry of Defence of the Russian Federation

Email: doctor-vma@mail.ru

Russian Federation Cand. Sci. (Med.), Doctoral Candidate, Department of Skin and Venereal Diseases

V. R. Khairutdinov

S.M. Kirov Military Medical Academy, Ministry of Defence of the Russian Federation

Author for correspondence.
Email: haric03@list.ru

Russian Federation Dr. Sci. (Med.), Associate Professor, Department of Skin and Venereal Diseases

A. V. Samtsov

S.M. Kirov Military Medical Academy, Ministry of Defence of the Russian Federation

Email: avsamtsov@mail.ru

Russian Federation Dr. Sci. (Med.), Prof., Departmental Head, Department of Skin and Venereal Diseases

References

  1. Gibbs S. Skin disease and socioeconomic conditions in rural Africa: Tanzania. Int J Dermatol. 1996;35(9):633–642.
  2. Danielsen K., Olsen A. O., Wilsgaard T., Furberg A. S. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population — based cohort. Br J Dermatol. 2013;168:1303–1310.
  3. Jiaravuthisan M. M., Sasseville D., Vender R. B. et al. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol. 2007;57(1):1–27.
  4. Crowley J., Weinberg J., Wu J. et al. Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation. JAMA Dermatol. 2015;151:87–94.
  5. Reich K. Approach to managing patients with nail psoriasis. Eur Acad Dermatol Venereol. 2009;23(1):15–21.
  6. Armesto S., Esteve A., Coto-Segura P. et al. Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients. Actas Dermosifiliogr. 2011;102:365–372.
  7. Parlo-Castello V., Pardo O. A. Disease of the nails. Springfield: Thomas, 1960. 48 p.
  8. Samman P. D. The nails in Disease. London: Heinemann, 1978. 238 p.
  9. Cassell S. E., Bieber J. D., Rich P. et al. The modified nail psoriasis severity index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol. 2007;3:123–132.
  10. Rich P., Scher R. K. Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49(2):206–212.
  11. Jong E. M., Menke H. E., van de Praag M. C., van De Kerkhof P. C. Dystrophic psoriatic fingernails treated with 1 % 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study. Dermatology. 1999;199:313–321.
  12. Jones S. M., Armas J. B., Cohen M. G. et al. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol.1994;33:834–843.
  13. Baran R. L. A nail psoriasis severity index. Br J Dermatol. 2004;150:568–577.
  14. Karlijn M. G., Klaassen M. D., Peter C. M. et al. Scoring nail psoriasis. J Am Acad Dermatol. 2014;6:1061–1066.
  15. Parrish C. A., Sobera J. O., Elewski B. E. Modification of the nail psoriasis severity index. J Am Acad Dermatol. 2005;53:745–751.
  16. Klaassen K. M. G., Dulak M. G., van de Kerkhof P. C. M., Pasch M. C. The prevalence of onychomycosis in psoriatic patients: systematic review. J Eur Acad Dermatol Venereol. 2014;28(5):533–574.

Statistics

Views

Abstract - 534

PDF (Russian) - 241

PlumX

Dimensions


Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies